Gross Margin
15.00%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 6.63%.Updated Aug 20, 2026Profit Margin
-23.59%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
3.35%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
-0.88%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
-12.80%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
676.74MCNY100.51M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
8.66CNYUpdated Aug 20, 2026Quarterly Revenue Growth
21.90%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
44.84MCNY6.66M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
76.34MCNY11.34M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
-159.63MCNY-23.71M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
61.49%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
29.46MCNY4.38M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
-368.70MCNY-54.76M · vs all stocks (USD) Updated Aug 20, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 20, 2026Minority Interest (Equity)
19.33MCNYFY2025 · Dec 31, 2025Revenue
595.41MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
542.78MCNYFY2025 · Dec 31, 2025Gross Profit
52.63MCNYFY2025 · Dec 31, 2025Operating Income
-7.55MCNY-1.12M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-174.95MCNYFY2025 · Dec 31, 2025Income Tax Expense
7.43MCNYFY2025 · Dec 31, 2025Net Income
-182.38MCNYFY2025 · Dec 31, 2025EBIT
-173.69MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
76.34MCNYFY2025 · Dec 31, 2025Research & Development
23.50MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
10.78MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.24MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
227.60KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.26MCNYFY2025 · Dec 31, 2025EPS (Basic)
-2.32CNYFY2025 · Dec 31, 2025EPS (Diluted)
-2.32CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
78.33MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
78.33MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-182.38MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
644.99KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-302.95MCNYFY2025 · Dec 31, 2025Free Cash Flow
-702.72MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
106.47MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-182.38MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.27MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-78.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-43.16MCNYFY2025 · Dec 31, 2025Capital Expenditures
-399.78MCNYFY2025 · Dec 31, 2025Sale of Investments
3.71MCNYFY2025 · Dec 31, 2025Other Investing Activity
150.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-246.07MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
351.67MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-74.63MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-12.79MCNYFY2025 · Dec 31, 2025Other Financing Charges
-14.05MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
250.20MCNYFY2025 · Dec 31, 2025